Leslie A. Miller serves as Executive at Better Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Leslie A. Miller has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 18, 2023 involved receiving (via award) 3,587 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 18, 2023 | BTTX | $0 | Award | 3,587 | $N/A | Planned |
Leslie A. Miller currently holds 17,937 shares of Better Therapeutics, Inc. (BTTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Leslie A. Miller has been a net neutral trader of BTTX stock. They have purchased $0 and sold $0 worth of shares.
Leslie A. Miller's most recent insider trade was on Dec 18, 2023, when they sold 3,587 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted